The global tissue diagnostics market is on a significant growth trajectory, with an estimated valuation of $5.3 billion in 2022, set to expand to $7.3 billion by 2027, at a robust CAGR of 6.6%. Key drivers for this growth include the escalating prevalence of cancer, particularly breast cancer, gastric cancer, and lung cancer, as well as the increasing emphasis on personalized medicine. However,...